2015 Fast Congress Banner  
  • Slide 2
  • Slide 3
  • Slide 1


 Dinner Short Courses:


Coverage Includes:

  • Organoids and Primary Organotypic 3D Culture in Drug Discovery
  • Phenotypic Screening for New Target, Pathway and Mechanism-of-Action Discovery
  • Phenotypic Screening Using Primary and Stem Cell-Derived Models
  • Case Studies in Phenotypic Drug Discovery
  • Engineering Functional Organ-on-a-Chip Models
  • 3D Spheroid Models for Drug Screening
  • Integrated Approach to in vitro Drug Discovery: Tissue Engineering Meets Systems Biology
  • Microengineered 3D Models for Drug Safety Testing
  • Phenotypic and High-Content Screening of 3D Models
  • Cancer-on-a-Chip: Engineering 3D Models of Tumor Microenvironment

Featured Speakers:

David SwinneyDavid C. Swinney

CEO, Institute for Rare and Neglected Diseases Drug Discovery (iRND3)

Per Erik StromstedtPer Erik Stromstedt

Director, Screening Sciences
AstraZeneca

Jeffrey MorganJeffrey Morgan

Professor, Medical Science & Engineering Brown University

Hicham AlaouiHicham Alaoui

Director, Cellular Pharmacology Genentech

Linda GriffithLinda G. Griffith

Professor, Biological Engineering, MIT

David GraingerDavid Grainger

Professor, Pharmaceutical Chemistry University of Utah

Sophie LelièvreSophie A. Lelièvre

Director, 3D Cell Culture Core Facility Purdue University

David TellersDavid Tellers

Principal Scientist, Discovery Chemistry Merck

Anne BangAnne Bang

Director, Cell-Based Disease Modeling and Screening, Sanford-Burnham-Prebys Medical Discovery Institute

Michael ShenMichael Shen

Professor, Medicine, Systems Biology Columbia University


About the Event:

Cambridge Healthtech Institute (CHI) is pleased to announce the Third Annual FAST: Functional Analysis and Screening Technologies Congress. Now in its third year, the FAST Congress brings you the latest technologies and research in cellular screening.

The Third Annual Phenotypic Drug Discovery meeting will return with new updates and case studies in phenotypic screening, high-content analysis, physiologically-relevant cellular models, chemical genomics and chemical proteomics. The rapidly evolving area of 3D cellular models will be addressed by two back-to-back meetings, with the Inaugural 3D Cell Culture: Organoid, Spheroid, and Organ-on-a-Chip Models meeting focusing on the new predictive cellular models for drug discovery and toxicity assessment. It will review the use of primary and stem cells, complex co-culture cell models, tumor spheroid models, novel organ-on-a-chip models for efficacy and safety screening, functional analysis, and compound profiling. The Third Annual Screening and Functional Analysis of 3D Models meeting will follow with case studies of phenotypic and high-content screening of complex 3D cellular systems for compound and target selection.

The 2014 Congress attracted more than 250 senior delegates, representing over 160 companies from 20 countries. With half of the attendees from big pharma and biotech and a third from academia and government, the FAST Congress offers exclusive networking opportunities with diverse international attendance. Please join our focused Screening event and learn from 60+ scientific presentations, an assortment of educational courses, 20+ exhibitors and your fellow expert delegates. We look forward to seeing you at the event.

Quotes